Interesting, the high level of IL-6 was also related with poor survival of chronic myeloid leukemia (CML) patients, and higher expression of IL-6 in CML cells is associated with the lower expression of SCF in MSCs in patients. Here, KITLG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.